Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Notice of Availability of Administrative Supplements to Promote Data Sharing in Cancer Epidemiology Studies NOT-CA-19-031 NCI N/A Notice Availability Administrative Supplements Promote Data Sharing Cancer Epidemiology Studies Notice Number: NOT-CA-19-031 Key Dates Release Date: March 12, 2019 Related Announcements PA-18-591… More
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) PAR-19-251 NCI The overall objective of this Funding Opportunity Announcement (FOA) is to support innovative research on adducts to cellular macromolecules as indicators of exposures to endogenous and exogenous… More
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) PAR-20-271 NCI The goal of this FOA is identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy… More
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) PAR-21-278 NCI The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities… More
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) PAR-21-318 NCI This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) RFA-CA-21-012 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P50 specialized centers.… More
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-20-043 NCI This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1)… More
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-19-193 NCI The overall purpose of this funding opportunity announcement (FOA) is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer… More
Notice of National Cancer Institute (NCI) Participation in PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed) NOT-CA-20-027 NCI N/A Notice National Cancer Institute NCI) Participation PAR-20-100 Genomic Community Resources U24 Clinical Trial Allowed)” Notice Number: NOT-CA-20-027 Key Dates Release Date: January 28, 2020 Related… More
Translational and Basic Science Research in Early Lesions (TBEL) Coordinating and Data Management Center (U24 Clinical Trial Not Allowed) RFA-CA-21-055 NCI The TBEL program aims to integrate basic and translational cancer research concepts to examine the direct causal relationships and interactions of an early lesion, its microenvironment, and host-… More
Updated: